Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 294

1.

Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?

Amiot L, Ferrone S, Grosse-Wilde H, Seliger B.

Cell Mol Life Sci. 2011 Feb;68(3):417-31. doi: 10.1007/s00018-010-0583-4. Epub 2010 Nov 10. Review.

2.

Polymorphisms in the genes encoding TGF-beta1, TNF-alpha, and IL-6 show association with type 1 diabetes mellitus in the Slovak population.

Javor J, Ferencik S, Bucova M, Stuchlikova M, Martinka E, Barak L, Strbova L, Grosse-Wilde H, Buc M.

Arch Immunol Ther Exp (Warsz). 2010 Oct;58(5):385-93. doi: 10.1007/s00005-010-0092-z. Epub 2010 Aug 5.

PMID:
20686866
3.

Soluble HLA-G is an independent factor for the prediction of pregnancy outcome after ART: a German multi-centre study.

Rebmann V, Switala M, Eue I, Grosse-Wilde H.

Hum Reprod. 2010 Jul;25(7):1691-8. doi: 10.1093/humrep/deq120. Epub 2010 May 19.

PMID:
20488801
4.

The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia.

Nückel H, Switala M, Sellmann L, Horn PA, Dürig J, Dührsen U, Küppers R, Grosse-Wilde H, Rebmann V.

Leukemia. 2010 Jun;24(6):1152-9. doi: 10.1038/leu.2010.74. Epub 2010 Apr 29.

PMID:
20428196
5.

Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation.

Rebmann V, Bartsch D, Wunsch A, Möllenbeck P, Golda T, Viebahn R, Grosse-Wilde H.

Hum Immunol. 2009 Dec;70(12):995-9. doi: 10.1016/j.humimm.2009.07.016. Epub 2009 Aug 6.

PMID:
19651178
6.

TNF-alpha and IL-10 gene polymorphisms show a weak association with pemphigus vulgaris in the Slovak population.

Javor J, Chmurova N, Parnicka Z, Ferencik S, Grosse-Wilde H, Buc M, Svecova D.

J Eur Acad Dermatol Venereol. 2010 Jan;24(1):65-8. doi: 10.1111/j.1468-3083.2009.03260.x. Epub 2009 Apr 8.

PMID:
19470040
7.

Association of common polymorphisms in known susceptibility genes with rheumatoid arthritis in a Slovak population using osteoarthritis patients as controls.

Stark K, Rovenský J, Blazicková S, Grosse-Wilde H, Ferencik S, Hengstenberg C, Straub RH.

Arthritis Res Ther. 2009;11(3):R70. doi: 10.1186/ar2699. Epub 2009 May 15.

8.

High CD49d protein and mRNA expression predicts poor outcome in chronic lymphocytic leukemia.

Nückel H, Switala M, Collins CH, Sellmann L, Grosse-Wilde H, Dührsen U, Rebmann V.

Clin Immunol. 2009 Jun;131(3):472-80. doi: 10.1016/j.clim.2009.02.004. Epub 2009 Mar 24.

PMID:
19318232
9.

Adoptive immune transfer of hepatitis B virus specific immunity from immunized living liver donors to liver recipients.

Schumann A, Lindemann M, Valentin-Gamazo C, Lu M, Elmaagacli A, Dahmen U, Knop D, Broelsch CE, Grosse-Wilde H, Roggendorf M, Fiedler M.

Transplantation. 2009 Jan 15;87(1):103-11. doi: 10.1097/TP.0b013e31818bfc85.

PMID:
19136899
10.

Diagnosis of tuberculosis infection in patients awaiting liver transplantation.

Lindemann M, Dioury Y, Beckebaum S, Cicinnati VR, Gerken G, Broelsch CE, Wrighton-Smith P, Grosse-Wilde H.

Hum Immunol. 2009 Jan;70(1):24-8. doi: 10.1016/j.humimm.2008.10.005. Epub 2008 Oct 31.

PMID:
18977260
11.

Mitoxantrone does not restore the impaired suppressive function of natural regulatory T cells in patients suffering from multiple sclerosis. A longitudinal ex vivo and in vitro study.

Putzki N, Kumar M, Kreuzfelder E, Grosse-Wilde H, Diener HC, Limmroth V.

Eur Neurol. 2009;61(1):27-32. doi: 10.1159/000165346. Epub 2008 Oct 24.

PMID:
18948697
12.

14th International HLA and Immunogenetics Workshop Prospective Chronic Rejection Project: a three-year follow-up analysis.

Ozawa M, Terasaki PI, Castro R, Alberu J, Morales-Buenrostro L, Alvarez I, Toledo R, Alvez H, Monteiro M, Teixeira J, Campbell P, Ciszek M, Charron D, Gautreau C, Christiansen F, Langan L, Conca R, Grosse-Wilde H, Heinemann F, Kamoun M, Kobayashi T, Kupatawintu P, LeFor W, Mehra N, Panigrahi A, Norman D, Piazza A, Poli F, Roy R, Schonemann C, Lachmann N, Sireci G, Tanabe K, Ishida H, Van den Berg-Loonen E, Zeevi A.

Clin Transpl. 2007:255-60.

PMID:
18642456
13.

Prevalence of latent tuberculosis infection in German radiologists.

Barsegian V, Mathias KD, Wrighton-Smith P, Grosse-Wilde H, Lindemann M.

J Hosp Infect. 2008 May;69(1):69-76. doi: 10.1016/j.jhin.2008.02.009. Epub 2008 Apr 10.

PMID:
18403047
14.

Detection of chromium allergy by cellular in vitro methods.

Lindemann M, Rietschel F, Zabel M, Grosse-Wilde H.

Clin Exp Allergy. 2008 Sep;38(9):1468-75. doi: 10.1111/j.1365-2222.2008.02970.x. Epub 2008 Mar 31.

PMID:
18384428
15.

Characterization of anti-HLA antibodies eluted from explanted renal allografts.

Heinemann FM, Roth I, Rebmann V, Arnold ML, Spriewald BM, Grosse-Wilde H.

Clin Transpl. 2006:371-8.

PMID:
18365391
16.

The clinical significance of soluble human leukocyte antigen class-I, ICTP, and RANKL molecules in multiple myeloma patients.

Schütt P, Rebmann V, Brandhorst D, Wiefelspütz J, Ebeling P, Opalka B, Seeber S, Nowrousian MR, Moritz T, Grosse-Wilde H.

Hum Immunol. 2008 Feb;69(2):79-87. doi: 10.1016/j.humimm.2008.01.006. Epub 2008 Feb 7.

PMID:
18361931
17.

HLA-G expression in malignant melanoma.

Rebmann V, Wagner S, Grosse-Wilde H.

Semin Cancer Biol. 2007 Dec;17(6):422-9. Epub 2007 Jun 28. Review.

PMID:
17689098
18.

HLA-G in B-chronic lymphocytic leukaemia: clinical relevance and functional implications.

Rebmann V, Nückel H, Dührsen U, Grosse-Wilde H.

Semin Cancer Biol. 2007 Dec;17(6):430-5. Epub 2007 Jun 28. Review.

PMID:
17683947
19.

Cellular and humoral immune response to a third generation hepatitis B vaccine.

Schumann A, Fiedler M, Dahmen U, Grosse-Wilde H, Roggendorf M, Lindemann M.

J Viral Hepat. 2007 Aug;14(8):592-8.

PMID:
17650294
20.

Single nucleotide polymorphisms of cytokine genes in the healthy Slovak population.

Javor J, Bucova M, Ferencik S, Grosse-Wilde H, Buc M.

Int J Immunogenet. 2007 Aug;34(4):273-80.

PMID:
17627763
21.

Immunoglobulin isotype-specific characterization of anti-human leukocyte antigen antibodies eluted from explanted renal allografts.

Heinemann FM, Roth I, Rebmann V, Arnold ML, Witzke O, Wilde B, Spriewald BM, Grosse-Wilde H.

Hum Immunol. 2007 Jun;68(6):500-6. Epub 2007 Mar 21.

PMID:
17509449
22.

14th International HLA and Immunogenetics Workshop: report on the Prospective Chronic Rejection Project.

Ozawa M, Terasaki PI, Lee JH, Castro R, Alberu J, Alonso C, Alvarez I, Toledo R, Alvez H, Monterio M, Teixeira J, Campbell P, Ciszek M, Charron D, Gautreau C, Christiansen F, Conca R, Gomez B, Monteon F, Grosse-Wilde H, Heinemann F, Humar I, Kamoun M, Kimball P, Kobayashi T, Kupatawintu P, Leech S, LeFor W, Mehra N, Panigrahi A, Naumova E, Norman D, Piazza A, Poli F, Colombo B, Roy R, Schonemann C, Sireci G, Tanabe K, Ishida H, Van den Berg-Loonen E, Zeevi A.

Tissue Antigens. 2007 Apr;69 Suppl 1:174-9.

PMID:
17445195
23.

Quantification and identification of soluble HLA-G isoforms.

Rebmann V, LeMaoult J, Rouas-Freiss N, Carosella ED, Grosse-Wilde H.

Tissue Antigens. 2007 Apr;69 Suppl 1:143-9.

PMID:
17445190
24.

Association of elevated pretransplant sCD30 levels with graft loss in 206 patients treated with modern immunosuppressive therapies after renal transplantation.

Heinemann FM, Rebmann V, Witzke O, Philipp T, Broelsch CE, Grosse-Wilde H.

Transplantation. 2007 Mar 27;83(6):706-11.

PMID:
17414702
25.

Rapid evaluation of soluble HLA-G levels in supernatants of in vitro fertilized embryos.

Rebmann V, Switala M, Eue I, Schwahn E, Merzenich M, Grosse-Wilde H.

Hum Immunol. 2007 Apr;68(4):251-8. Epub 2006 Dec 22.

PMID:
17400060
26.

Relevance of C1 and C2 epitopes for hemopoietic stem cell transplantation: role for sequential acquisition of HLA-C-specific inhibitory killer Ig-like receptor.

Fischer JC, Ottinger H, Ferencik S, Sribar M, Punzel M, Beelen DW, Schwan MA, Grosse-Wilde H, Wernet P, Uhrberg M.

J Immunol. 2007 Mar 15;178(6):3918-23.

27.

Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients.

Rebmann V, Schütt P, Brandhorst D, Opalka B, Moritz T, Nowrousian MR, Grosse-Wilde H.

Clin Immunol. 2007 Apr;123(1):114-20. Epub 2007 Jan 10.

PMID:
17218152
28.

Donor cell reaction to OKT3 as predictor of chronic graft-vs-host disease in hematopoietic stem cell recipients.

Lindemann M, Ottinger HD, Elmaagacli AH, Trenschel R, Rebmann V, Beelen DW, Grosse-Wilde H.

Exp Hematol. 2006 Dec;34(12):1753-8.

PMID:
17157173
29.

CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis.

Kumar M, Putzki N, Limmroth V, Remus R, Lindemann M, Knop D, Mueller N, Hardt C, Kreuzfelder E, Grosse-Wilde H.

J Neuroimmunol. 2006 Nov;180(1-2):178-84. Epub 2006 Sep 29.

PMID:
17011048
30.

Increased frequencies of CD8+ T lymphocytes recognizing wild-type p53-derived epitopes in peripheral blood correlate with presence of epitope loss tumor variants in patients with hepatocellular carcinoma.

Cicinnati VR, Zhang X, Yu Z, Ferencik S, Schmitz KJ, Dworacki G, Kaczmarek E, Oldhafer K, Frilling A, Baba HA, Schmid KW, Grosse-Wilde H, Broelsch CE, DeLeo AB, Gerken G, Beckebaum S.

Int J Cancer. 2006 Dec 15;119(12):2851-60.

31.

Immune parameters in multiple myeloma patients: influence of treatment and correlation with opportunistic infections.

Schütt P, Brandhorst D, Stellberg W, Poser M, Ebeling P, Müller S, Buttkereit U, Opalka B, Lindemann M, Grosse-Wilde H, Seeber S, Moritz T, Nowrousian MR.

Leuk Lymphoma. 2006 Aug;47(8):1570-82.

PMID:
16966269
32.

Soluble HLA-G in rheumatoid arthritis.

Verbruggen LA, Rebmann V, Demanet C, De Cock S, Grosse-Wilde H.

Hum Immunol. 2006 Aug;67(8):561-7. Epub 2006 May 5.

PMID:
16916651
33.

Expression and function of Toll-like receptor 9 in severely injured patients prone to sepsis.

Baiyee EE, Flohe S, Lendemans S, Bauer S, Mueller N, Kreuzfelder E, Grosse-Wilde H.

Clin Exp Immunol. 2006 Sep;145(3):456-62.

34.

Detection of anti-MICA antibodies in patients awaiting kidney transplantation, during the post-transplant course, and in eluates from rejected kidney allografts by Luminex flow cytometry.

Zou Y, Heinemann FM, Grosse-Wilde H, Sireci G, Wang Z, Lavingia B, Stastny P.

Hum Immunol. 2006 Mar;67(3):230-7. Epub 2006 Mar 30.

PMID:
16698447
35.

ELISpot assay as a sensitive tool to detect cellular immunity following influenza vaccination in kidney transplant recipients.

Lindemann M, Witzke O, Lütkes P, Fiedler M, Kreuzfelder E, Philipp T, Roggendorf M, Grosse-Wilde H.

Clin Immunol. 2006 Sep;120(3):342-8. Epub 2006 Apr 21.

PMID:
16631409
36.

Sequence-based typing reveals a novel DLA-88 allele, DLA-88*04501, in a beagle family.

Hardt C, Ferencik S, Tak R, Hoogerbrugge PM, Wagner V, Grosse-Wilde H.

Tissue Antigens. 2006 Feb;67(2):163-5.

PMID:
16441490
37.

Mutations in innate immune system NOD2/CARD 15 and TLR-4 (Thr399Ile) genes influence the risk for severe acute graft-versus-host disease in patients who underwent an allogeneic transplantation.

Elmaagacli AH, Koldehoff M, Hindahl H, Steckel NK, Trenschel R, Peceny R, Ottinger H, Rath PM, Ross RS, Roggendorf M, Grosse-Wilde H, Beelen DW.

Transplantation. 2006 Jan 27;81(2):247-54.

PMID:
16436969
38.

Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004.

Rebmann V, Lemaoult J, Rouas-Freiss N, Carosella ED, Grosse-Wilde H.

Hum Immunol. 2005 Aug;66(8):853-63. Epub 2005 Jul 20.

PMID:
16216668
39.

Behcet's disease is associated with increased concentrations of antibodies against phosphatidylserine and ribosomal phosphoproteins.

Berlit P, Stueper B, Fink I, Rebmann V, Hoyer P, Kreuzfelder E, Grosse-Wilde H.

Vasa. 2005 Aug;34(3):176-80.

PMID:
16184836
40.

Reduced risk for molecular disease in patients with chronic myeloid leukemia after transplantation from a KIR-mismatched donor.

Elmaagacli AH, Ottinger H, Koldehoff M, Peceny R, Steckel NK, Trenschel R, Biersack H, Grosse-Wilde H, Beelen DW.

Transplantation. 2005 Jun 27;79(12):1741-7.

PMID:
15973179
41.

What is the impact of HLA mismatches detected by high-resolution techniques on the outcome of unrelated donor bone marrow transplantation?

Ottinger HD, Beelen DW, Grosse-Wilde H.

Bone Marrow Transplant. 2005 Jun;35(12):1211. No abstract available.

PMID:
15834436
42.

In vitro dendritic cell generation and lymphocyte subsets in myeloma patients: influence of thalidomide and high-dose chemotherapy treatment.

Schütt P, Buttkereit U, Brandhorst D, Lindemann M, Schmiedl S, Grosse-Wilde H, Seeber S, Nowrousian MR, Opalka B, Moritz T.

Cancer Immunol Immunother. 2005 May;54(5):506-12. Epub 2004 Nov 20.

PMID:
15750834
43.

G-CSF-induced alteration of in vitro alloreactivity in stem cell donors is predictive for the occurrence of acute GVHD in recipients.

Lindemann M, Grosse-Wilde H, Ottinger HD, Peceny R, Beelen DW.

Transplantation. 2005 Feb 15;79(3):377-8. No abstract available.

PMID:
15699777
44.

Cellular in vitro immune function in multiple myeloma patients after high-dose chemotherapy and autologous peripheral stem cell transplantation.

Lindemann M, Schuett P, Moritz T, Ottinger HD, Opalka B, Seeber S, Nowrousian MR, Grosse-Wilde H.

Leukemia. 2005 Mar;19(3):490-2. No abstract available.

PMID:
15674357
45.

T-cell function after interleukin-2 therapy in HIV-infected patients is correlated with serum cortisol concentrations.

Lindemann M, Witzke O, Winterhagen T, Ross B, Kreuzfelder E, Reinhardt W, Roggendorf M, Mann K, Philipp T, Grosse-Wilde H.

AIDS. 2004 Oct 21;18(15):2001-7.

PMID:
15577621
46.

rhG-CSF effect on mixed lymphocyte cultures and circulating soluble HLA antigen levels in volunteer stem cell donors.

Lindemann M, Rebmann V, Ottinger HD, Schmolke K, Kreuzfelder E, Grosse-Wilde H.

Exp Hematol. 2004 Nov;32(11):1103-9.

PMID:
15539089
47.
48.

Increased levels of interleukin-10 in serum from patients with hepatocellular carcinoma correlate with profound numerical deficiencies and immature phenotype of circulating dendritic cell subsets.

Beckebaum S, Zhang X, Chen X, Yu Z, Frilling A, Dworacki G, Grosse-Wilde H, Broelsch CE, Gerken G, Cicinnati VR.

Clin Cancer Res. 2004 Nov 1;10(21):7260-9.

49.

Impact of HLA-A,B,C allele mismatches on outcome after unrelated blood stem cell transplantation in whites.

Ottinger HD, Ferencik S, Beelen DW, Lindemann M, Peceny R, Elmaagacli AH, Grosse-Wilde H.

Transplantation. 2004 Oct 15;78(7):1077-80.

PMID:
15480178
50.

HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia.

Nückel H, Rebmann V, Dürig J, Dührsen U, Grosse-Wilde H.

Blood. 2005 Feb 15;105(4):1694-8. Epub 2004 Oct 5.

PMID:
15466928

Supplemental Content

Loading ...
Support Center